No news on Pfizer’s Covid-19 vaccine is good news — and bad news Pfizer and BioNTech are under a white-hot spotlight because their vaccine, by design, is likely to be the first to have any efficacy data. Matthew Herper STAT

Pfizer revealed Tuesday that researchers have not yet conducted an analysis of the efficacy of the vaccine it is developing against Covid-19.

The announcement is both good news and bad news. 

Europe swept by COVID wave amid anger at new curbs European governments prepared on Tuesday to introduce new restrictions to try to curb a growing surge of coronavirus infections and provide economic balm to help businesses survive the pandemic. Crispian Balmer U.S.

ROME (Reuters) - European governments prepared on Tuesday to introduce new restrictions to try to curb a growing surge of coronavirus infections and provide economic balm to help businesses survive the pandemic.

Europe warns of grim winter as COVID second wave gathers pace European leaders warned of a bleak winter as resurgent COVID-19 infections forced countries to impose new restrictions to try to curb a second wave of the pandemic, with the United States and France setting new daily records for cases. James Mackenzie U.S.

MILAN (Reuters) - European leaders warned of a bleak winter as resurgent COVID-19 infections forced countries to impose new restrictions to try to curb a second wave of the pandemic, with the United States and France setting new daily records for cases.

FDA shows concern over emergency authorization of Covid-19 vaccines The ageny may be exploring the idea of using expanded access — a more limiting program — in the early days of Covid vaccine rollouts. Helen Branswell STAT

There are serious signs the Food and Drug Administration is getting cold feet over the notion of issuing emergency use authorizations to allow for the widespread early deployment of Covid-19 vaccines.